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Abstract
Amyotrophic lateral sclerosis (ALS) is
a progressive neurodegenerative disease
characterized by motoneuron death. Several
cellular pathways have been described to be
involved in ALS pathogenesis; however, the
involvement of presynaptic stripping and
the related MHC class I molecules in
mutant SOD1 motoneurons remains to be
clarified. To this purpose, we here investi-
gated, for the first time, the motoneurons
behavior, di per se and after facial axonal
injury, in terms of synaptic stripping and
MHC class I expression in wild-type (Wt)
mice and in a murine model of ALS, the
SOD1(G93A) mice, at the presymptomatic
and symptomatic stage of the disease.
Concerning Wt animals, we found a reduc-
tion in synaptophysin immunoreactivity and
an increase of MHC class I molecules in
facial motoneurons after axotomy. In unin-
jured motoneurons of SOD1(G93A) mice,
an altered presynaptic framework was evi-
dent, and this phenomenon increased during
the disease course. The alteration in the
presynaptic input is related to excitatory
fibers. Moreover, after injury, a further
decrease of excitatory input was not associ-
ated to an upregulation of MHC class I mol-
ecules in motoneuron soma. This study
demonstrates, for the first time, that the
presence of mutated SOD1 protein affects
the MHC class I molecules expression,
altering the presynaptic input in motoneu-
rons. Nevertheless, a positive MHC class I
immunolabeling was evident in glial cells
around facial injured motoneurons, under-
lying an involvement of these cells in
synaptic stripping. This study contributes to
better understand the involvement of the
mutated SOD1 protein in the vulnerability
of motoneurons after damage.
Introduction
Amyotrophic lateral sclerosis (ALS) is
a fatal disease characterized by progressive
loss of cortical, bulbar, and spinal motoneu-
rons leading to muscle atrophy, weakness,
fasciculations, spasticity, and paralysis. The
incidence of ALS is 2-3/100,000 cases and
the disease is fatal within 3-5 years after
clinical onset due to respiratory failure.1
Several mechanisms have been implicated
in the pathogenesis of ALS, including mito-
chondrial damage, glutamate excitotoxicity,
oxidative stress, protein aggregation, neuro-
filament accumulation and neuroinflamma-
tion.2 However, few studies have focused on
the role of the presynaptic motoneuron
compartment and on the involvement of
major histocompatibility complex I (MHC
class I)-related molecules in the pathogene-
sis of ALS.
The expression of activity of MHC
class I molecules, a set of classical immune
molecules involved in antigen presentation,
was first described in the CNS, playing a
non-immune role in development and plas-
ticity.3-5 Moreover, an unexpected role has
been attributed to MHC class I molecules in
the detachment of afferent synaptic boutons
from injured neurons.6 Their expression has
been associated with signaling mediating
strength of synapse elimination, a phenom-
enon known as “synaptic stripping”, that
occurs to limit the excitatory input resulting
in a positive effect on regenerative capacity
after axonal injury.6,7 The MHC class I was
seen upregulated in motoneurons after mice
sciatic nerve transection8 in which a retro-
grade response at the cell body consisting of
removal of synapses from the perikaryon
and dendrites occurs.9,10
The synapses, and in particular, presy-
naptic terminals have been implicated as
early sites of dysfunction following injury
in the nervous system and in neurodegener-
ative diseases.11 Neuropathological studies
on spinal cord tissue obtained from ALS
patients revealed a significant reduction of
presynaptic terminals at distal portions of
dendrites with relative preservation of peri-
somatic and proximal dendrite terminals in
the gray matter of the anterior horn.12-15
Other studies showed a reduction of synap-
tic boutons on the soma and proximal den-
drites of chromatolytic or atrophic anterior
horn neurons, with no changes in normal-
appearing neurons.16,17 However, a signifi-
cant decrease in cell body area, number of
synapses and total synaptic length have
been reported also in normal-appearing
lumbar motoneurons of ALS cases.18 Most
of these studies assessed changes in the
immunosignal of the presynaptic vesicle
membrane protein, synaptophysin, in presy-
naptic terminals on the soma and proximal
dendrites of spinal cord motoneurons and
surrounding neuropil. Data from studies on
a murine model of the familial form of ALS,
SOD1(G93A) mice, revealed an overall
decrease in synaptic boutons on lumbar
motoneurons and interneurons at disease
onset and during disease progression.19
Moreover, an imbalance in synaptic input to
these motoneurons was found related to dis-
ease progression, with overall over inhibi-
tion.20 However, the role of the mutated
SOD1 gene in MHC class I molecules
expression and in the synaptic stripping
after axonal injury has not been yet eluci-
dated in facial motoneurons, that are not
involved in the typical neurodegeneration
of ALS.
On these bases, our study aims to evalu-
ate, following axonal injury, the behavior of
mutant SOD1 motoneurons in relation to the
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expression of MHC class I molecules.
Moreover, since the expression of these mol-
ecules is associated with the synaptic strip-
ping, the study of the presynaptic terminal
was examined. To this purpose, we analyzed
the reaction of facial motoneurons to axoto-
my in mutant SOD1(G93A) mice (mSOD1)
at the presymptomatic and symptomatic
stage of disease compared to wild-type (Wt)
littermates. Since in this murine model the
cranial motoneurons are affected later during
ALS progression, the alteration of MHC
class I expression and the synaptic stripping
should be due to mutant SOD1. We here
examined possible differences in the strength
of synaptic stripping from the perikarya of
facial motoneurons of presymptomatic and
symptomatic mSOD1 mice compared to Wt
littermates after unilateral facial nerve axoto-
my. Quantitative assessment of perisomatic
synaptophysin-immunopositive boutons and
size of injured facial motoneurons compared
to intact ones were done in the three groups
of mice. The expression of MHC class I mol-
ecules in axotomized facial motoneurons of




Transgenic mice carrying a mutated
human SOD1 gene (strain designation:
B6SJL-TgN[SOD1-G93A]1Gur) were
originally obtained from Jackson
Laboratories (Bar Harbor, ME, USA). The
animals were kept under controlled envi-
ronmental parameters and veterinarian
assistance. All experiments were carried out
with the authorization of the Committee for
Research on Laboratory Animals of the
University of Verona and the Italian
Ministry of Health, following the NIH
Guide for the Use and Care of Laboratory
Animals, in accordance with the current
European Communities Council Directives
(2010/63/UE), minimizing the number of
animals used and avoiding their sufferance.
Transgenic progeny, derived from the
colony established in our animal facility,
was identified by polymerase chain reaction
specific for human SOD1 with G93A muta-
tion, as outlined by the Jackson
Laboratories. The time of disease onset in
our colony was around 85-95 days, consis-
tent with reports from other colonies of the
same strain.21
In all mSOD1 mice, the onset and pro-
gression of disease were carefully moni-
tored. The absence of tremors and intact
extension reflex indicated the presympto-
matic stage (60-65 days), while mSOD1
mice were referred to as symptomatic (95-
105 days) when they exhibited tremors, no
extension reflex, hindlimb retraction and
dragging hindlimbs.
Tracer injection and facial nerve
axotomy
Under anesthesia (chloral hydrate; 50
mg/kg, i.p.), presymptomatic (n=4) and
symptomatic (n=4) mSOD1, and age-
matched Wt mice (n=8) received bilateral
intramuscular injections of the FluoroGold
(FG; Fluorochrome LLC, Denver, CO,
USA) in the mystacial pads. In particular, 5
µL of 3% FG in 0.01M phosphate-buffered
saline, pH 7.4 (PBS) was administered in
three injection sites among the five rows of
mystacial vibrissae. These mice were des-
tined for the study on changes in the expres-
sion of synaptophysin on the soma of facial
motoneurons in a paradigm of slow, ongo-
ing neurodegeneration. FG labeling is char-
acterized by fluorescent granules in the
soma sparing the nucleus and processes of
neurons.22 Good FG labeling of facial
motoneurons was obtained in the rat 10
days after injection in the mystacial pad,23
and in our study which utilized mice a
shorter time of 7 days was selected.
A week after FG injection, under deep
anaesthesia (chloral hydrate; 50 mg/kg,
i.p.), the left buccal and mandibular branch-
es of the facial nerve were cut 2 mm from
the exit of the nerve trunk from the stylo-
mastoid foramen, and a 1-mm long segment
of each branch was cut in order to impede
regeneration. Unilateral facial nerve axoto-
my was also done in a group of mice, (Wt
n= 8; presymptomatic mSOD1 n=4; symp-
tomatic mSOD1 n=4) with no precedent FG
injection in the whisker pads, for the study
on MHC class I expression. Motor deficits
indicated by paralysis of vibrissae move-
ment and nasal tip deviation were observed
on the injured side in all mice throughout
the post-axotomy survival period. None of
the mice exhibited impairment of the facial
muscles on the intact side evaluated through
the vibrissae orientation and movement. We
focused 14 days (synaptophysin and MHC
class I) after axotomy as this is the most
informative time point after facial nerve
injury in mice, as shown in our previous
report.24
Perfusion, tissue processing and
immunohistochemistry
Under deep anesthesia (pentobarbital,
60 mg/kg, i.p.), all mice were perfused tran-
scardially with PBS followed by a fixative
solution of 4% paraformaldehyde in 0.1 M
phosphate buffer, pH 7.4 (PB). The brain-
stems were dissected out and put in 20%
sucrose in PBS at 4°C overnight. 
After cryoprotection, the brainstems
destined for the study on synaptophysin
were snap frozen in liquid nitrogen and
stored at -80°C until further processing. At
the time of cutting, the tissue was allowed
to thaw to -20°C in the cryostat chamber for
30 min, embedded in optimal cutting tem-
perature compound, cut into 20 µm-thick
transverse cryosections and mounted on
slides. The remaining brainstems, allocated
to the study on MHC class I molecules,
were cut into 30 µm-thick sections on a
freezing microtome and collected in culture
plates. All sections containing the facial
motor nucleus were collected and divided
into adjacent series of every fifth section. To
visualize presynaptic terminals together
with the perikarya of facial motoneurons,
double immunofluorescence for synapto-
physin and FG was done. For this, one
series of sections were preincubated for 2 h
in 3% bovine serum albumin (BSA) and
0.2% Triton X-100 in PB and then incubat-
ed for 48 h with rabbit polyclonal anti-FG
antibody (Chemicon, Temecula, CA, USA;
1:2500) in 3% BSA and 0.5% Triton-X-100.
The mouse monoclonal anti-synaptophysin
antibody (Chemicon; 1:500) which labels
presynaptic boutons, was added at mid-
incubation, i.e., after 24 h. After repeated
washing, the sections were incubated for 2 h
in Cy3 F(ab’)2 fragment goat anti-rabbit
IgGs (Jackson ImmunoResearch
Laboratories, West Grove, PA, USA; 1:100)
and fluorescein horse anti-mouse (Vector,
Burlingame, CA, USA; 1:200) in 1% BSA
and 0.2% Triton X-100 in PB. After rinsing,
sections were air-dried and coverslipped
with an anti-fading mounting medium
(Dako, Glostrup, Denmark).
Single immunohistochemistry for light
microscopy was, on the other hand, per-
formed for MHC class I molecules. Free-
floating sections were incubated for 15 min
in 0.3% H2O2 to quench endogenous perox-
idase and preincubated for 2 h in 3% BSA
and 0.2% Triton X-100 in PBS. They were
then incubated overnight in monoclonal
mouse anti-mouse H-2Kb/H-2Db antibody
(BD Pharmingen, Erembodegem, Belgium;
1:200), which recognizes the classical H-
2Kb and H-2Db MHC class I alloantigens, in
3% BSA in PBS. After rinsing, the sections
were incubated for 2 h in biotinylated horse
anti-mouse IgGs (Vector; 1:200) in 1%
BSA in PBS. The reaction was developed
with the avidin-biotin-peroxidase kit (ABC
kit; Vector) using 3-3’-diaminobenzidine as
chromogen. No immunopositivity was seen
in control sections processed by eliminating
primary antibodies. After mounting on
slides, the sections were dehydrated through
increasing grades of ethanol, cleared in
xylene, and coverslipped with Entellan
(Merck, Darmstadt, Germany).
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Data analysis
Sections processed for immunoperoxi-
dase were observed under the microscope
under bright-field illumination. 
Immunofluorescence was analyzed
with a Zeiss LSM 510 confocal laser scan-
ning microscope, in a dual-channel acquisi-
tion setup, using 488 nm and 543 nm exci-
tation beams. Facial motoneurons were
identified by their FG-immunolabelling.
Images of randomly-selected facial
motoneurons from the intact and axo-
tomized sides (n=10/side from two sec-
tions/animal at similar levels of the facial
motor nucleus) were collected. Under iden-
tical conditions, including constant pinhole
size for both excitation beams in a merged
mode, Z-axis image stacks of 1024x1024
pixels/image were acquired with a 63x
water immersion objective (1.40 numerical
aperture) and 1.2x scan zoom. The optimal
distance between stacks was automatically
adjusted to fit the axial sampling. Care was
taken in setting confocal laser scanning
parameters to allow optimal visualization of
punctuating staining on neural cell mem-
branes with clear contours of immunoposi-
tive puncta and good resolution among con-
tiguous ones. For quantitative analysis of
the number of presynaptic boutons on the
perikarya of sampled facial motoneurons
and measurement of the perimeter of
respective neurons, the software Zeiss LSM
Image Browser was used. Immunolabelled
presynaptic boutons were considered to be
in juxtaposition to FG-immunolabelled
facial motoneurons when no space was vis-
ible between the bouton and the neuronal
cell membrane in an optical section. On Z-
stack images consisting of the whole 3-
dimensional extent of sampled neurons, a
single neuron was zoomed in on and per-
pendicular lines dividing the neuron into
quadrants that were drawn using the
‘Overlay’ function. Focusing on one quad-
rant at a time on the first to the last optical
section containing a selected neuron, the
number of boutons touching the cell surface
were counted manually after comparing
with adjacent optical sections to avoid dou-
ble counting. Minor adjustments in the con-
trast of images were made whenever neces-
sary to have a clearer separation between
puncta. The perimeter of sampled facial
motoneurons was measured by tracing the
outline by using the ‘Overlay’ function.
Synaptic bouton density over the entire
motoneuron cell bodies was computed as a
ratio of the total number of synaptic bou-
tons/neuron to the perimeter.
Evaluation of synapses at transmis-
sion electron microscopy
Under deep anesthesia, presymptomatic
(n=4) and symptomatic (n=4) SOD1-mutant
mice, and age-matched Wt (n=8) mice were
perfused transcardially with PBS followed
by a fixative solution of 2.5% glutaralde-
hyde and 2% paraformaldehyde in 0.1 M
PB, pH 7.4. The brainstem regions contain-
ing the facial motor nucleus were dissected
out and immersed in the same fixative solu-
tion for 3 h at 4°C, post-fixed with 1% OsO4
at 4°C for 1 h, dehydrated with acetone and
embedded in Epon 812.
Ultrathin sections (70-90 nm) were
placed on copper grids and observed in a
Philips Morgagni transmission electron
microscopy apparatus equipped with a
Megaview II camera for digital image acqui-
sition and a computerized image analysis
system (AnalySIS Image processing, Soft
Imaging System GmbH, Muenster,
Germany). For morphometrical analyses of
synapses, 5 motoneurons cut in the nuclear
plane were considered in each facial motor
nucleus per animal. The cellular perimeter
and the length of the synaptic terminals
opposing to the motoneuron somata were
measured; then, the number of synapses per
100 µm cell membrane and the percentage of
cell membrane covered by the synaptic ter-
minals were calculated. The terminals were
classified into asymmetric synapses with
spherical (S) synaptic vesicles, considered to
be excitatory in nature, and symmetric
synapses with flattened (F) synaptic vesicles,
associated with inhibitory neurotransmitter.25
Statistical evaluation
The between-group difference in the
total number of synaptic boutons (total bou-
ton count/side/neuron/group) and synaptic
density (synaptic density/side/neuron, i.e.,
ratio of total bouton count/side/neuron to
neuron perimeter/group) and the numbers
of type S and F fibers on 100 µm cell
perimeter were analyzed with a 2-way
analysis of variance and Bonferroni post-
hoc test. Statistical analysis was performed
using a routine written in Matlab 7.1.
Significance was set at P<0.05.
Results
Bright retrograde fluorescent tracer
FG-labeling of facial motoneurons on the
intact and axotomized sides was obtained in
all three groups of animals: Wt, presympto-
matic and symptomatic SOD1(G93A) mice.
Synaptophysin immunoreactivity
Synaptophysin is the most commonly
used immunohistological marker for the
identification and quantitative assessment
of synapses.26 Synaptophysin immunostain-
ing was seen as fine granules on the surface
of the soma of neurons and throughout the
neuropil, as previously described.27
In the facial motor nucleus, attenuated
synaptophysin immunosignal was detected
on the side of injury compared to the con-
tralateral one in all three groups of animals
(Figure 1). Upon detailed examination, in
Wt mice, areas devoid of synaptophysin-
immunopositive boutons were detected on
the perikarya of axotomized facial
motoneurons, identified by FG-immunola-
belling, compared to those from the intact
side (Figure 1A,D). Quantitative evaluation
of the synaptophysin-immunoreactive
presynaptic terminals revealed a reduction
in the number of synapses on Wt axo-
tomized facial motoneurons compared to
uninjured ones (P=0.00001; Figure 2A).
Analysis of the synaptic density, on the
other hand, showed a significant decrease in
Wt facial motoneurons after axotomy
(P=0.00001; Figure 2B). Interestingly, in
presymptomatic SOD1(G93A) mice, seg-
ments of the surface of the soma lacking
synaptic boutons were detected on unin-
jured facial motoneurons compared to intact
cells from Wt mice (Figure 1 A,B).
Following axotomy, a detachment of presy-
naptic terminals in injured presymptomatic
SOD1(G93A) facial motoneurons were
found compared to the intact side (Figure 1
B,E). Intriguingly, the number and density
of synapses on intact facial motoneurons
from presymptomatic mSOD1 mice were
similar to that in axotomized Wt ones, while
they are different to that of uninjured Wt
(mean number P=0.0020; mean synaptic
density P= 0.0013. Figure 2 A,B).
Moreover, a decrease in the number of
synaptic boutons (P=0.00001) and in the
synaptic density (P=0.00001) (Figure 2
A,B) was found in injured presymptomatic
SOD1(G93A) facial motoneurons com-
pared to the intact side. In addition, the axo-
tomized presymptomatic mSOD1 motoneu-
rons had less number (P=0.0007) and densi-
ty (P=0.0018) of synapses compared to axo-
tomized Wt cells (Figure 2 A,B).The unin-
jured facial motoneurons from symptomatic
mSOD1 mice showed stretches of the sur-
face of the soma compared to uninjured Wt
neurons (Figure 1 A,C). Moreover, a reduc-
tion of synaptic boutons after axotomy was
detected, similar to Wt and presymptomatic
SOD1(G93A) mice (Figure 1 C,F).
Concerning the uninjured facial motoneu-
rons from symptomatic mSOD1 mice, there
was a tendency towards a reduction in the
number of synapses compared to uninjured
Wt (Figure 2A). The synapse loss from
uninjured facial motoneurons from sympto-
matic mSOD1 mice was not different from
that found in presymptomatic mice and par-
alleled the synaptic stripping in axotomized
Wt motoneurons (Figure 2A). Synaptic den-
sity, on the other hand, was significantly
reduced in intact facial motoneurons from










symptomatic mSOD1 mice compared to
unlesioned Wt (P=0.00001; Figure 2B). As
in both Wt and presymptomatic
SOD1(G93A) mice, following axotomy, in
symptomatic mSOD1 mice, a significant
loss of synaptic boutons (P=0.00001) and
decreased synaptic density (P=0.00001)
was found on injured motoneurons com-
pared to intact ones (Figure 2 A,B).
Furthermore, synaptic density on axo-
tomized facial motoneurons from sympto-
matic mSOD1 mice was significantly
reduced compared to axotomized Wt
motoneurons (P=0.00001; Figure 2B).
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Figure 1. Synaptophysin immunofluorescent staining. Double immunofluorescent staining of the facial motor nucleus for synapto-
physin (green) and FluoroGold (red) 14 days after facial nerve resection. Arrows indicate areas devoid of synaptophysin-immunoreac-
tive boutons. Axotomy, axotomized side; Control, intact side; Wt, wild-type; mSODp, presymptomatic SOD1(G93A); mSODs, symp-
tomatic SOD1(G93A). Scale bar: 20 µm.
Figure 2. Synaptic boutons and density. Graphs showing the mean values and respective standard deviations for synaptic boutons (A)
and synaptic density (B) of wild-type (Wt), presymptomatic SOD1(G93A) (mSODp) and symptomatic SOD1(G93A) (mSODs) mice.
The black columns indicate the intact side, grey columns indicate the axotomized side. In the figure are shown the statistically signif-












The ultrastructural examination of
synapsis confirms the synaptophysin
immunolabeling results, in which a reduc-
tion of the presynaptic boutons between Wt
and SOD1(G93A) mice was evaluated. In
Figure 3 are reported the representative
TEM images of excitatory and inhibitory
synapsis. It is important to underline that
the presynaptic buttons reduction is particu-
larly related to excitatory fibers (types S)
instead to inhibitory one (type F), as shown
in Figure 4A.
The excitatory fibers input on unle-
sioned facial motoneurons of presympto-
matic mutant SOD1 mice is already com-
promised compared to Wt, showing a sig-
nificant statistical reduction (P=0.00001) of
the type S fiber number (11.06 and 20.77
number of type S/100 µm cell perimeter in
                             Original Paper
Figure 3. Synapses ultrastructure. Representative transmission electron micrographs of an asymmetric (excitatory) synapsis with spher-
ical vesicles (A), and a symmetric (inhibitory) synapsis showing typically flattened vesicles (arrow) (B). Scale bars: 200 nm.
Figure 4. Excitatory and inhibitory fibers. Graphs showing the morphological examination of synapsis of wild-type (Wt), presympto-
matic SOD1(G93A) (mSODp) and symptomatic SOD1(G93A) (mSODs) mice. In A are reported the results concerning the number of
excitatory fibers (type S)/100 µm of cell perimeter; in B are reported the results concerning the number of inhibitory fibers (type F)/100
µm of cell perimeter. The black columns indicate the intact side, grey columns indicate the axotomized side. In the figure are shown
some of the statistically significant differences (*P<0.0033; ***P<0.000066).










presymptomatic mSOD1 and Wt mice
respectively; Figure 4A). This data indicate
that the excitatory input is already altered at
the presymptomatic stage of the disease.
Moreover, during the disease course, a fur-
ther reduction of excitatory fibers input
occurs in intact facial motoneurons, show-
ing a significant statistical difference com-
pared to Wt (P=0.00001) and presympto-
matic mSOD1 mice (P=0.00001; Figure
4A). After axotomy, in Wt mice, a 50% of
excitatory fiber reduction was found (10.94
of S fibers on 100 µm cell perimeter) and
this trend was detected also in presympto-
matic and symptomatic mSOD1 mice (6.17
and 3.35 of S fibers on cell perimeter
respectively; Figure 4B). Concerning type F
fibers, no statistical significance was
observed comparing the axotomized and
unlesioned side of three groups of animals
(Figure 4B), indicating a selective loss of
type S fibers after injury. Moreover, no sta-
tistical difference was observed between
unlesioned Wt and presymptomatic
mSOD1 mice. This indicates that mSOD1
facial motoneurons injured behave as Wt,
modulating the excitatory input and not
inhibitory one.
MHC class I immunoreactivity
In Wt mice, MHC class I molecules
expression was detected in uninjured facial
motoneurons, evidenced by faint immuno-
labelling of the rims of the cytoplasm of
intact one (Figure 5 A,B). In axotomized
facial motoneurons of Wt mice, the MHC I
immunolabelling pattern show an intense,
homogenous and diffuse staining of the cell
body (Figure 5 C,D). The expression of
MHC class I molecules was detected as
faint immunolabelling also in the uninjured
facial motoneurons of mSOD1, as in Wt
mice.  After axotomy, in presymptomatic
mSOD1 mice, MHC class I immunola-
belling was seen inside motoneurons with a
diffuse distribution over the cell body that
seems to decrease in intensity compared to
Wt (Figure 5 C,D-E,F). In symptomatic
mSOD1 mice, it was evident an upregula-
tion in the expression of MHC class I pro-
tein on the lesioned side compared to the
intact one (data not shown) and compared
to Wt and presymptomatic mSOD1 mice
showed an immunolabelling limited to
markedly activated microglia, recognized
by morphology (Figure 5).
Discussion
Murine SOD1(G93A) facial motoneu-
rons represent a model to study the involve-
ment of the mutant SOD1 gene in ALS and
to examine their dieback response after axo-
tomy, since they do not die during the dis-
ease course,28 differently to human ALS.2
Our data in SOD1(G93A) facial
motoneurons show a diminished number of
presynaptic terminals compared to Wt. The
number and density of presynaptic termi-
nals in intact facial motoneurons of mSOD1
mice were decreased compared to Wt,
underlining that mutated SOD1 facial
motoneurons show a compromised presy-
naptic input. Interestingly, loss of excitatory
input and unchanged inhibitory input,
resulting in over-inhibition rather than over-
excitation, was reported in lumbar
motoneurons from symptomatic
SOD1(G93A) mice.20 In accordance to this,
we demonstrate that the altered presynaptic
input in facial motoneurons regards the
excitatory fibers instead to inhibitory ones.
The decrease of the number and density of
presynaptic terminals in mSOD1 mice were
more evident in symptomatic compared to
the presymptomatic animals, indicating
that, despite this motoneurons do not die,
their impairment increase during the disease
course. Since it is reported that excitatory
synaptic stripping occurs in motoneurons
after injury as a defense mechanism,6 we
retain that the excitatory fibers reduction
observed in our study serves to counteract
the excitotoxic influence on uninjured
mutated SOD1 motoneurons, indicating
that the SOD1 mutation di per se induces a
pathological motoneuron condition.
Following axotomy, the number of
detached synapses did not seem to vary
with progression of the disease in this ALS
murine model. However, a reduction in
synapse density was found to correlate with
the progression of the disease and the axo-
tomized mSOD1 facial motoneurons had a
significant decrease in synaptic density
compared to injured Wt counterparts.
Early and gradual loss of synapses is a
pathological feature common to ALS dis-
ease.29 This process has been extensively
studied in the spinal motoneurons, directly
affected by the neurodegeneration, during
the disease course, allowing to study the
synaptic stripping in degenerating motoneu-
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Figure 5. MHC class I molecules immunolabeling. In Wt mice, note a faint immunolabelling of MHC class I molecules expression in
uninjured facial motoneurons (A,B). MHC class I immunolabeling in the axotomized facial motor nucleus of wild-type (Wt) (C,D),
presymptomatic SOD1(G93A) (mSODp) (E,F) and symptomatic SOD1(G93A) (mSODs) (G,H) mice 14 days after axotomy. Scale
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rons. The decrease in the number and densi-
ty of synaptophysin-immunoreactive bou-
tons from the soma and proximal dendrites
of lumbar motoneurons and interneurons of
SOD1(G93A) mice was found at disease
onset, with ongoing loss through disease
progression.19 However, this study does not
allow to correlate the synaptic stripping to
the SOD1 mutation. Our findings on facial
motoneurons of SOD1(G93A) mice showed
a reduced number of presynaptic terminals
compared to the Wt even before any signs
of disease, indicating a selective involve-
ment of the mutated SOD1 gene in the vul-
nerability of the motoneurons after damage.
Interesting differences between Wt and
transgenic mice in the upregulation of the
expression of MHC class I molecules in
facial motoneurons following axotomy
were also detected. Comparing
SOD1(G93A) mice to the Wt, the expres-
sion of MHC class I molecules decrease
during the progression of the disease. MHC
class I molecules, classically thought to
mediate exclusively immune function, have
been implicated in neuronal signaling in
vivo and activity-dependent changes in
synaptic connectivity.5 Moreover, it has
been reported that MHC class I protein can
be located at both pre- and post-synaptic
level in the healthy CNS30 and its expres-
sion increased after injury, playing a poten-
tial role in reparative processes and mediat-
ing synaptic stripping. In relation to this, an
injury cell response is represented by soma
presynaptic terminal elimination, that pri-
marily involves excitatory input instead of
inhibitory fibers,6 that seem to be preserved.
This process leads to a surplus of inhibitory
influence on injured neurons and may be of
benefit by directing the cellular mechanism
towards repair rather than information pro-
cessing.31 This “neuroprotective” response
to peripheral nerve lesion may thus be
impaired in mSOD1 mice. Moreover,
impaired MHC class I signaling has been
associated with an impediment in regenera-
tive capacity.32,33 Studies in six weeks old
dystrophic MDX mice showed a reduced
synaptic activity in intact lumbar motoneu-
rons, more intense synaptic detachment and
lower MHC I upregulation compared to the
Wt following sciatic nerve transection.34
Intriguingly, inducible nitric oxide synthase
knockout mice showed increased synaptic
stripping and decreased MHC class I
expression around axotomized lumbar
motoneurons compared to the Wt.35
Impairment in the activation of the nitrergic
and purinergic systems in facial motoneu-
rons in response to facial nerve axotomy
has been previously described in this mouse
model of familial ALS.24,36
The data from the present study show
that mSOD1 expression alters motoneurons
functionality, that attempt to counteract the
intracellular damage altering the excitatory
presynaptic input. Despite MHC class I
molecules seem to have an effect on synap-
tic stripping inducing regeneration, in
SOD1(G93A) motoneurons after injury we
did not find an upregulation in MHC class I
molecules expression compared to Wt,
although an excitatory synaptic stripping
occurs. The presence of mSOD1 protein
could interfere with MHC class I expres-
sion: it is known that the ubiquitin-protea-
some system, whose functionality is altered
in ALS, is involved in the generation of
MCH class I molecules.37 Moreover, the
crosstalk between damaged motoneurons
and glia could induce the microglial cells to
express MHC I in order to induce synaptic
stripping. It was already hypothesized an
involvement of microglial cells in synaptic
stripping after facial nerve transection.38 In
fact, we found, in SOD1(G93A) facial
nucleus, an MHC immunolabelling limited
to activated microglia, which underlies a
potential role of microglial cells in presy-
naptic removal. Since in motoneurons of
SOD1(G93A) mice there is an impairment
of MHC production, we believe that the
synaptic rearrangement could be due to
MHC express by microglia. The role of
mutated microglia in the ALS disease is
controversial and there is evidence that its
beneficial/detrimental role depends on its
different phenotypes (M1 and M2) during
the disease progression.39,40 In our study, the
MHC I expression in microglial cells could
indicate its protective role in the non-late
stage of the disease of mice, trying to rescue
axotomized motoneurons from death.
In summary, our data provide new evi-
dence of the importance of MHC class I in
synaptic stripping, and the better under-
standing of the complex scenario that
occurs in presence of mutated SOD1 pro-
tein could help to develop new strategies to
rescue ALS motoneurons.
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